Nganou-Makamdop, Krystelle <br/><br/>
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.  [electronic resource] 

 -  PLoS pathogens  08 2018 
 - e1007246 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1553-7374 
<br/><br/><label>Standard No.: </label>10.1371/journal.ppat.1007246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Retroviral Agents--pharmacology<br/>Chronic Disease<br/>Inflammation--immunology<br/>Interferon Type I--antagonists & inhibitors<br/>Lymphocyte Activation--drug effects<br/>Macaca mulatta<br/>Receptors, Interferon--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Simian Acquired Immunodeficiency Syndrome--drug therapy<br/>Simian Immunodeficiency Virus--drug effects<br/>T-Lymphocytes--drug effects<br/>Virus Replication--drug effects